Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)

Guru Subramanian Guru Guru Murthy, MBBS, Scott H. Kaufmann, MD PhD, Aniko Szabo, PhD, Arielle Baim, Ashish Anshu, Alexander Hinman, Laura C. Michaelis, MD, Sameem Abedin, MD, Karen-Sue B. Carlson, MD PhD, Lyndsey Runaas, MD, Ehab L. Atallah, MD

Blood (2019) 134 (Supplement_1): 3837.

https://doi.org/10.1182/blood-2019-131728

Published: 2019

Journal Articles

Epigenomic Signatures in Myelodysplastic Syndrome Patients As Predictors of Donor Compatibility and Transplant Outcome

Wei Wang, Paul Auer, PhD, Stephen R. Spellman, MS, Karen-Sue B. Carlson, MD PhD, Aziz Nazha, MD, Martin Maiers, MS, Yung-Tsi Bolon, Wael Saber, MD MS

Blood (2019) 134 (Supplement_1): 4557.

https://doi.org/10.1182/blood-2019-127124

Published: 2019

Journal Articles

The Prognostic Significance of Blast Aberrancies By Flow Cytometry in Low/Int Risk MDS

Kristen M Corrao, MD, Alexandra M. Harrington, MDMT(ASCP), Steven H. Kroft, MD, Laura C. Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Lyndsey Runaas, MD, Ehab L. Atallah, MD, Sameem Abedin, MD

Blood (2019) 134 (Supplement_1): 5430.

https://doi.org/10.1182/blood-2019-130511

Published: 2019

Journal Articles

Phase I Study of Pracinostat in Combination with Gemtuzumab Ozogamicin (PraGO) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Talha Badar, MD, Guru Subramanian Guru Murthy, MD, Lyndsey Runaas, MD, Karen-Sue B. Carlson, MD PhD, Laura C. Michaelis, MD, Alexandra M. Harrington, MDMT(ASCP), Ehab L. Atallah, MD, Sameem Abedin, MD

Blood (2019) 134 (Supplement_1): 5068.

https://doi.org/10.1182/blood-2019-123237

Published: 2019

Journal Articles

Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

Muhammad Umair Mushtaq, MD, Sibgha Gull Chaudhary, MD, Laura C. Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Sameem Abedin, MD, Lyndsey Runass, MD, Michael J. Fallon, PharmD, Alexandra M. Harrington, MD, Mark Juckett, MD, Aric C. Hall, MD, Ryan J. Mattison, MD, Ehab L. Atallah, MD, Guru Subramanian Guru Murthy, MBBS

Blood (2018) 132 (Supplement 1): 2708.

https://doi.org/10.1182/blood-2018-99-113764

Published: 2018

Journal Articles

Reducing Venous Thrombosis with Antithrombin Supplementation in Patients Undergoing Treatment for ALL with Asparaginase Based Regimens

Alexandra Rezazadeh, MD, Gemlyn George, MD, Nicole Pearl, PharmD, Cole McCoy, Felicia Zook, Benjamin Jung, Aschenbrenner Emilie, Mindy Waggoner, Sameem Abedin, MD, Lyndsey Runaas, MD, Laura C. Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Lisa Baumann Kreuziger, MD MS, Ehab L. Atallah, MD

Blood (2018) 132 (Supplement 1): 1232.

https://doi.org/10.1182/blood-2018-99-114597

Published: 2018

Journal Articles

40 Is the New 50: Reducing the Need for Platelet Transfusions Prior to Lumbar Puncture in Patients with Hematologic Malignancies

Kristen M Corrao, MD, Laura C. Michaelis, MD, Lisa Baumann Kreuziger, MD MS, Karen-Sue B. Carlson, MD PhD, Sameem Abedin, MD, Elizabeth Malosh, MSN, RN, David Atkinson, Wenjing Shan, Stephen Quinet, MD MPH, Adrian P Umpierrez De Reguero, MD, DeLisle Julie, RN, MSN, Angela Treml, MD, Lyndsey Runaas, MD, Ehab L. Atallah, MD

Blood (2018) 132 (Supplement 1): 4837.

https://doi.org/10.1182/blood-2018-99-114264

Published: 2018

Journal Articles

Successful Implementation of a Blood Management Program for Patients with Hematologic Malignancies

Kristen Corrao, MD, Kathleen Hemauer, MD, Tina Curtis, DNP, MBA, RN, NEA-BC, Dave Atkinson, Laura C. Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Jerome Gottschall, MD, Ehab Atallah, MD

Blood (2017) 130 (Supplement 1): 2160.

https://doi.org/10.1182/blood.V130.Suppl_1.2160.2160

Published: 2017

Journal Articles

Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals

Adam Levin, MD, Ariel Kleman, MD, Lisa Rein, MS, Sergey Tarima, PhD, Laura C Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Parameswaran Hari, MBBS, MD MRCP, Ehab Atallah, MD, Binod Dhakal, MD MS

Blood (2016) 128 (22): 2784.

https://doi.org/10.1182/blood.V128.22.2784.2784

Published: 2016

Journal Articles

Physiologic Hematopoiesis Is Dependent on Stromal Expression of Laminin-Î³1

Sreemanti Basu, PhD, Irene Hernandez, MS, Mark Zogg, BS, Hartmut Weiler, PhD, Karen-Sue B. Carlson, MD PhD, Pouneh Kermani, PhD

Blood (2015) 126 (23): 3596.

https://doi.org/10.1182/blood.V126.23.3596.3596

Published: 2015

Journal Articles

Regulation of Hematopoiesis By the Coagulation Receptor Thrombomodulin

Sreemanti Basu, PhD, Irene Hernandez, MS, Mark Zogg, BS, Karen-Sue B. Carlson, MD PhD, Hartmut Weiler

Blood (2015) 126 (23): 4750.

https://doi.org/10.1182/blood.V126.23.4750.4750

Published: 2015

Journal Articles

Ruxolitinib Prior to Allogeneic Stem Cell Transplantation Does Not Adversely Affect Post-Transplant Outcomes

Ahmad Hanif, MD, Parameswaran N. Hari, MD MRCP, MS, Ehab Atallah, MD, Karen-Sue B. Carlson, MD PhD, Marcelo C. Pasquini, MD, Laura C Michaelis, MD

Blood (2014) 124 (21): 1851.

https://doi.org/10.1182/blood.V124.21.1851.1851

Published: 2014

Journal Articles

Laminin Expression Is Necessary for Maintenance of the Vascular Hematopoietic Niche

Pouneh Kermani, PhD, Anita Ramnarain, Raul Catena, PhD, Zu-Lin Chen, MD, PhD, Barbara Hempstead, MD, PhD, Sidney Strickland, PhD, Karen-Sue B. Carlson, MD, PhD

Blood (2011) 118 (21): 217.

https://doi.org/10.1182/blood.V118.21.217.217

Published: 2011

Journal Articles

A Novel Sequential Treatment Utilizing CPX-351 As Salvage Chemotherapy Followed by a Reduced Intensity Conditioning Allogeneic Stem-Cell Transplantation for Patients with Refractory Leukemia

Usama Gergis, MD, Gail J. Roboz, MD, Ellen Ritchie, MD, Joseph M. Scandura, MD, PhD, Karen-Sue B. Carlson, MD, PhD, Tsiporah B. Shore, MD, Sebastian Mayer, MD, Tomer M Mark, MD, MSc, Roger N Pearse, MD, PhD, June Greenberg, Tania J Curcio, R.N, Cindy Ippoliti, PharmD, Marshall McKenna, Eric J Feldman, MD

Blood (2011) 118 (21): 3030.

https://doi.org/10.1182/blood.V118.21.3030.3030

Published: 2011

Journal Articles

Disruption of Laminin-γ1 Expression Induces Rapid Decrease In Spleen Size.

Karen-Sue B. Carlson, MD, PhD, Pouneh Kermani, PhD, Ramnarain Anita, Zu-Lin Chen, MD, PhD, Strickland Sidney, PhD

Blood (2010) 116 (21): 2596.

https://doi.org/10.1182/blood.V116.21.2596.2596

Published: 2010

NARROW

A Multisite Phase Ib Study of Pevonedistat, Azacitidine and Venetoclax (PAVE) for the Treatment of Subjects with Acute Myelogenous Leukemia (AML)

Epigenomic Signatures in Myelodysplastic Syndrome Patients As Predictors of Donor Compatibility and Transplant Outcome

The Prognostic Significance of Blast Aberrancies By Flow Cytometry in Low/Int Risk MDS

Phase I Study of Pracinostat in Combination with Gemtuzumab Ozogamicin (PraGO) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

Reducing Venous Thrombosis with Antithrombin Supplementation in Patients Undergoing Treatment for ALL with Asparaginase Based Regimens

40 Is the New 50: Reducing the Need for Platelet Transfusions Prior to Lumbar Puncture in Patients with Hematologic Malignancies

Successful Implementation of a Blood Management Program for Patients with Hematologic Malignancies

Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals

Physiologic Hematopoiesis Is Dependent on Stromal Expression of Laminin-Î³1

Regulation of Hematopoiesis By the Coagulation Receptor Thrombomodulin

Ruxolitinib Prior to Allogeneic Stem Cell Transplantation Does Not Adversely Affect Post-Transplant Outcomes

Laminin Expression Is Necessary for Maintenance of the Vascular Hematopoietic Niche

A Novel Sequential Treatment Utilizing CPX-351 As Salvage Chemotherapy Followed by a Reduced Intensity Conditioning Allogeneic Stem-Cell Transplantation for Patients with Refractory Leukemia

Disruption of Laminin-γ1 Expression Induces Rapid Decrease In Spleen Size.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only